Article and Video CATEGORIES

Cancer Journey

Search By

Search here for cancer terms and phrases within cancerGRACE.org, and find tons of great information available on the GRACE website.

ABOUT
Howard (Jack) West, MD
Howard Jack West, MD, Founder, Board President

Dr. Jack West is a medical oncologist and thoracic oncology specialist who is the Founder and previously served as President & CEO, currently a member of the Board of Directors of the Global Resource for Advancing Cancer Education (GRACE)

 

Read More
Dr. Leighl's Highlights in Lung Cancer, 2012: ALK- and ROS1-positive NSCLC
Dr West
Author
Howard (Jack) West, MD

ALK positiveDr. Leighl, lung cancer expert from Princess Margaret Hospital in Toronto, continued her summary of the leading highlights in lung cancer from 2012 with coverage of new information on XALKORI for patients with either an ALK rearrangement or the newly identified ROS-1 rearrangement.  

The video and audio versions of the podcast on this part of her program are below, along with the figures:

[powerpress]

Dr. Leighl Highlights in LC 2012 Pt 2 ALK and ROS Rearr NSCLC Audio Podcast

Dr. Leighl Highlights in LC 2012 Pt 2 ALK and ROS Rearr NSCLC Figs

More of her presentation coming very soon!

Tags
Advanced NSCLC
ALK mutation
ALK Rearrangement
crizotinib
EML4-ALK
Highlights in Lung Cancer 2012
HSP90 inhibition
LDK378
Lung Cancer
Natasha Leighl
Princess Margaret Hospital
ROS-1
ROS1
ROS1 rearrangement
University of Toronto
XALKORI

Please feel free to offer comments and raise questions in our
discussion forums.

 Join The conversation

Next Previous link

Previous PostNext Post

Related Content

La Revolución de la Biopsia Líquida: Un Cambio Radical en el Cuidado del Cáncer
Article
Las biopsias líquidas están revolucionando la forma en que combatimos el cáncer, ofreciendo un futuro donde la detección y el tratamiento son más rápidos, precisos y menos invasivos.
Videoteca de Cáncer de Pulmon - 2025
Videoteca de Cáncer de Pulmón en Español 2025
Video
Como parte de la Videoteca de Cáncer de Pulmón en Español 2025, oncólogos expertos discuten las opciones de tratamiento y la información más emergente en cáncer de pulmón. El Dr. Raez aborda la terapia para cánceres de pulmón EGFR y ALK, además de analizar otros tres temas de actualidad. La Dra. Viola y la Dra. Riaño también contribuyen a esta videoteca, cada una presentando tres temas relevantes sobre el cáncer de pulmón.
Unlocking Precision in Lung Cancer: Understanding and Overcoming Resistance to EGFR and ALK Inhibitors
Article
The journey to conquer lung cancer is paved with scientific discovery, and the identification of the EGFR and ALK genes as crucial players marks a significant milestone. Unraveling how mutations in these seemingly small segments of our DNA can unleash the destructive force of cancer has opened up exciting new therapeutic avenues. This exploration delves into the cutting-edge world of EGFR and ALK-targeted therapies, highlighting the progress made and the ongoing quest for even more effective and personalized strategies to combat this formidable disease.

Forum Discussions

Recent Comments

JOIN THE CONVERSATION
Pain Management - 1252271
Looking to buy Buy Adderall online? Telegram Username:@drmike100
By declanshore2 on
New here and scared
Hi there, thank you for…
By kidjaialai on
Comparing which scan for swelling above clavicle and near throat - supraclavicular lymph nodes?
Hi Hopish hope,  Welcome to…
By JanineT GRACE … on
Comparing which scan for swelling above clavicle and near throat - supraclavicular lymph nodes?
colon cancer and HIV
By Hopish hope on